Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00623090 · ClinicalTrials.gov registry record · Phase 3
Internet-Based Education for Prostate Cancer Screening
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,893
- Enrollment target
NCT00623090: Completed Phase 3 study, sponsored by Georgetown University.
NCT00623090 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 1,893 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (145% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00623090, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,893 participants
- Enrollment target
Study Summary
Prostate cancer (PCa) is the leading cancer diagnosis among men and the second leading cause of male cancer death. However, screening asymptomatic men remains controversial, as early diagnosis and treatment of PCa has not yet demonstrated reduced disease-related mortality in a randomized trial. The goal of the current study is to develop and assess widely accessible methods to assist men in making informed decisions about PCa screening. We will compare the efficacy of a new web-based, interactive decision support approach to our existing print-based PCa screening decision tool, among a diverse sample of male primary care patients. Abundant evidence documents the expanding role of the Internet in increasing access to and understanding of health information and the need for systematic evaluations of Internet-based interventions. A novel aspect of the proposed trial will be our focus on cognitive biases as a factor that has limited the success of previous information-based interventions. Specifically, we will evaluate: 1) confirmation bias and 2) short-term consequences bias.
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL educational internet site on prostate cancer screening
- BEHAVIORAL Educational print booklet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,893 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-08 |
| Phase | Phase 3 |
What the finished NCT00623090 record still lists
NCT00623090 is an interventional study that assigns participants to a tested intervention. Its 1,893 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (145% higher).
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT00623090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00623090 about?
NCT00623090 is a clinical study titled "Internet-Based Education for Prostate Cancer Screening". Prostate cancer (PCa) is the leading cancer diagnosis among men and the second leading cause of male cancer death. However, screening asymptomatic men remains controversial, as early diagnosis and treatment of PCa has not yet demonstrated reduced disease-related mortality in a randomized trial. The ...
What is the current status of trial NCT00623090?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,893 participants. The study started on 2007-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00623090?
The interventions under investigation include: Usual care (BEHAVIORAL), educational internet site on prostate cancer screening (BEHAVIORAL), Educational print booklet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00623090?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00623090's enrollment target sits among peer trials
1,893 113th of 2000 higher than 1,888 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07308717 · 1,896 participants · Phase 4
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia